BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4228960)

  • 1. Circadian rhythm in serum 5-hydroxytryptamine of healthy men and male patients with mental retardation.
    Halberg F; Anderson JA; Ertel R; Berendes H
    Int J Neuropsychiatry; 1967 Aug; 3(4):379-86. PubMed ID: 4228960
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of tryptophan to plasma proteins and the rate of the inactivation of 5HT released from platelets in Down's syndrome.
    Airaksinen EM; Airaksinen MM
    Ann Clin Res; 1972 Dec; 4(6):361-5. PubMed ID: 4267141
    [No Abstract]   [Full Text] [Related]  

  • 3. Circadian variation of serotonin levels in human blood.
    Sauerbier I; von Mayersbach H
    Horm Metab Res; 1976 Mar; 8(2):157-8. PubMed ID: 1261971
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of immunoglobulins in mongolism, in epilepsy and in unclassified mental deficiency.
    van Rootselaar FJ; Boerma FW
    Psychiatr Neurol Neurochir; 1968; 71(6):501-7. PubMed ID: 4181929
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in Down's syndrome. IV. Investigations on the "Xh" factor.
    Rittner C; Rittner B
    Clin Genet; 1973; 4(5):407-9. PubMed ID: 4270856
    [No Abstract]   [Full Text] [Related]  

  • 6. Down's syndrome: a study of sleep patterns related to level of mental retardation.
    Castaldo V
    Am J Ment Defic; 1969 Sep; 74(2):187-90. PubMed ID: 4309776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood serotonin concentration in different forms of mental retardation].
    Isaev DM; Mikirtumov BE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):741-4. PubMed ID: 5122138
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in 5-hydroxytryptamine and its metabolites in neuropsychiatric disorders [proceedings].
    Sandler M
    Psychopharmacol Bull; 1981 Jan; 17(1):19-21. PubMed ID: 7232651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood zinc content in some mental disorders in children].
    Sorokina TT; Tereshkovich ZS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1575-8. PubMed ID: 4257933
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y; Kaneko M; Yashima Y; Kumashiro H
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of bio-clinical parameters and intelligence in subjects with Down's syndrome and other retardates.
    Klebba JT; Gershbein LL; Marks R
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):159-80. PubMed ID: 4277109
    [No Abstract]   [Full Text] [Related]  

  • 12. Circadian variation in 5-hydroxytryptamine levels in human blood.
    Sauerbier I; von Mayersbach H
    Chronobiologia; 1976; 3(2):131-5. PubMed ID: 789033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome.
    Cavani S; Tamaoka A; Moretti A; Marinelli L; Angelini G; Di Stefano S; Piombo G; Cazzulo V; Matsuno S; Shoji S; Furiya Y; Zaccheo D; Dagna-Bricarelli F; Tabaton M; Mori H
    Am J Med Genet; 2000 Nov; 95(3):224-8. PubMed ID: 11102927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet abnormalities in aggressive subjects with mental deficiency.
    Marazziti D; Palego L; Silvestri S; Presta S; Balestri C; Batistini A; Conti L
    J Psychiatry Neurosci; 1996 Mar; 21(2):109-13. PubMed ID: 8820176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distributions and correlates of serum albumin levels in institutionalised individuals with intellectual and/or motor disabilities.
    Ohwada H; Nakayama T
    Br J Nutr; 2008 Dec; 100(6):1291-6. PubMed ID: 18405401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biogenic amine metabolism in patients with oligophrenia of different origins].
    Bulakhova LA; Usherenko LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1563-7. PubMed ID: 6229120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in Down's syndrome. II. Association studies with blood, serum and enzyme groups, and with the Au-SH antigen.
    Rittner C; Schwinger E
    Clin Genet; 1973; 4(5):398-406. PubMed ID: 4270855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multiendocrine changes in patients with neurological lesions].
    Marescotti V; Saba P; Pariante F; Galeone F
    Actual Endocrinol (Paris); 1973; 13(0):190-7. PubMed ID: 4793600
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality of people with mental retardation in California with and without Down syndrome, 1986-1991.
    Strauss D; Eyman RK
    Am J Ment Retard; 1996 May; 100(6):643-53. PubMed ID: 8735577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.